blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3706732

EP3706732 - NEW USES OF LIPOPHENOLIC COMPOUNDS [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  31.03.2023
Database last updated on 17.09.2024
FormerRequest for examination was made
Status updated on  14.08.2020
FormerThe international publication has been made
Status updated on  18.05.2019
Formerunknown
Status updated on  17.11.2018
Most recent event   Tooltip13.10.2023New entry: Reply to examination report 
13.10.2023New entry: Renewal fee paid 
Applicant(s)For all designated states
Université de Montpellier
163, rue Auguste Broussonnet
34090 Montpellier / FR
For all designated states
Centre National de la Recherche Scientifique - CNRS
3, rue Michel-Ange
75016 Paris / FR
For all designated states
Ecole Nationale Supérieure de Chimie
240 Avenue du Professeur Émile Jeanbrau
34090 Montpellier / FR
For all designated states
Institut de Recherche pour le Développement (IRD)
Immeuble le Sextant
44, Bd de Dunkerque
CS 90009
13002 Marseille 2 / FR
For all designated states
Universite d'Aix-Marseille
58 boulevard Charles Livon
13007 Marseille / FR
For all designated states
Université Côte d'Azur
Grand Château
28 avenue Valrose
06100 Nice / FR
[N/P]
Former [2020/42]For all designated states
Université de Montpellier
163, rue Auguste Broussonnet
34090 Montpellier / FR
For all designated states
Centre National de la Recherche Scientifique - CNRS
3, rue Michel Ange
75016 Paris / FR
For all designated states
Ecole Nationale Supérieure de Chimie
240 Avenue du Professeur Émile Jeanbrau
34090 Montpellier / FR
For all designated states
Institut de Recherche pour le Développement (IRD)
Immeuble le Sextant
44, Bd de Dunkerque
CS 90009
13002 Marseille 2 / FR
For all designated states
Universite d'Aix-Marseille
58 boulevard Charles Livon
13007 Marseille / FR
For all designated states
Université Côte d'Azur
Grand Château
28 avenue Valrose
06100 Nice / FR
Former [2020/38]For all designated states
Université de Montpellier
163, rue Auguste Broussonnet
34090 Montpellier / FR
For all designated states
Centre National de la Recherche Scientifique - CNRS
3, rue Michel Ange
75016 Paris / FR
For all designated states
Ecole Nationale Supérieure de Chimie
240 Avenue du Professeur Émile Jeanbrau
34090 Montpellier / FR
For all designated states
Institut de Recherche pour le Développement (IRD)
Immeuble le Sextant
44, Bd de Dunkerque
CS 90009
13002 Marseille 2 / FR
For all designated states
Universite d'Aix-Marseille
58 boulevard Charles Livon
13007 Marseille / FR
For all designated states
COMMUNAUTE UNIVERSITES ET ETABLISSEMENTS UNIVERSITE COTE D'AZUR
Grand Chateau
28 Avenue Valrose
06100 Nice / FR
Inventor(s)01 / CRAUSTE, Céline
577 rue de Centrayrargues
34070 Montpellier / FR
02 / VERCAUTEREN, Joseph
301 chemin de Caylus
34170 Castelnau Le Lez / FR
03 / VEAS, Fransisco
Mas Abrigas Route de Baillargues
34130 Mauguio / FR
04 / DURAND, Thierry
2 rue Pierre Boissier
34070 Montpellier / FR
05 / BLONDEAU, Nicolas
185 route de Saint Pierre de Féric
06000 Nice / FR
 [2020/38]
Representative(s)Regimbeau
20, rue de Chazelles
75847 Paris Cedex 17 / FR
[2020/38]
Application number, filing date18796967.012.11.2018
[2020/38]
WO2018EP80915
Priority number, dateEP2017030656010.11.2017         Original published format: EP 17306560
[2020/38]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019092239
Date:16.05.2019
Language:EN
[2019/20]
Type: A1 Application with search report 
No.:EP3706732
Date:16.09.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 16.05.2019 takes the place of the publication of the European patent application.
[2020/38]
Search report(s)International search report - published on:EP16.05.2019
ClassificationIPC:A61K31/23, A61K31/231, A61K31/232, C07C69/22, C07C69/587, A61P9/14
[2020/38]
CPC:
A61K31/23 (EP); A61K31/235 (US); A61K31/231 (EP);
A61K31/232 (EP); C07C69/22 (EP); C07C69/587 (EP);
Y02A50/30 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/38]
TitleGerman:NEUE VERWENDUNGEN VON LIPOPHENOLEN VERBINDUNGEN[2020/38]
English:NEW USES OF LIPOPHENOLIC COMPOUNDS[2020/38]
French:NOUVELLES UTILISATIONS DE COMPOSÉS LIPOPHÉNOLIQUES[2020/38]
Entry into regional phase19.05.2020National basic fee paid 
19.05.2020Designation fee(s) paid 
19.05.2020Examination fee paid 
Examination procedure19.05.2020Examination requested  [2020/38]
19.05.2020Date on which the examining division has become responsible
18.12.2020Amendment by applicant (claims and/or description)
31.03.2023Despatch of a communication from the examining division (Time limit: M06)
10.10.2023Reply to a communication from the examining division
Fees paidRenewal fee
29.09.2020Renewal fee patent year 03
26.10.2021Renewal fee patent year 04
25.10.2022Renewal fee patent year 05
12.10.2023Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO9323075  (ONCOLOGIX INC [US], et al) [Y] 1-15 * claim - *;
 [X]WO2005069998  (UNIV BRIGHAM YOUNG [US], et al) [X] 14 * page 35, lines 5-6,15; claim 22 * * pages 8, 45 *;
 [Y]WO2006123178  (IMMUNOCLIN LTD [GB], et al) [Y] 1-15 * claim - *;
 [XY]WO2015162265  (INST NAT SANTE RECH MED [FR], et al) [X] 1-12 * pages 24-28; claim - * [Y] 1-15;
 [X]  - Pany, "PKC Activation by Resveratrol Derivatives with Unsaturated Aliphatic Chain", PLoS ONE 7(12): e52888. doi:10.1371/ journal.pone.0052888, (20121221), URL: http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0052888&type=printable, (20180227), XP055454605 [X] 14 * page 2; figure 1 *
 [Y]  - Fulgenzi, "In Vivo Inhibition of TNFa-Induced Vascular Permeability by Resveratrol", Transplantation Proceedings, 33, 2341-2343 (2001), (20010101), pages 2341 - 2343, URL: https://ac.els-cdn.com/S0041134501020152/1-s2.0-S0041134501020152-main.pdf?_tid=spdf-19d3c9c1-b684-4146-a68b-3bea3abf418e&acdnat=1519659657_0f2067fceb86ebca0128169f609cde59, (20180226), XP055454461 [Y] 1-15 * page 2342 *
 [Y]  - NADIA CALABRISO ET AL, "Red Grape Skin Polyphenols Blunt Matrix Metalloproteinase-2 and -9 Activity and Expression in Cell Models of Vascular Inflammation: Protective Role in Degenerative and Inflammatory Diseases", MOLECULES, (20160829), vol. 21, no. 12, doi:10.3390/molecules21091147, page 1147, XP055454556 [Y] 1-15 * pages 7-8 *

DOI:   http://dx.doi.org/10.3390/molecules21091147
 [Y]  - LEE BEOBYI ET AL, "Resveratrol inhibits TNF-alpha-induced proliferation and matrix metalloproteinase expression in human vascular smooth muscle cells", THE JOURNAL OF NUTRITION, AMERICAN SOCIETY FOR NUTRITION, US, (20051201), vol. 135, no. 12, ISSN 0022-3166, pages 2767 - 2773, XP009503755 [Y] 1-15 * abstract *
 [XP]  - ALY SHAMSEDDIN ET AL, "Resveratrol-Linoleate protects from exacerbated endothelial permeability via a drastic inhibition of the MMP-9 activity", BIOSCIENCE REPORTS, US, (20180619), vol. 38, no. 4, doi:10.1042/BSR20171712, ISSN 0144-8463, XP055540761 [XP] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1042/BSR20171712
by applicant   - BERGE et al., "Pharmacologically acceptable salts", J. Pharm. Sd, (19770000), vol. 66, page 1
    - BLASI, E.; BARLUZZI, R.; BOCCHINI, V. et al., "Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus", J. Neuroimmunol., (19900000), vol. 27, doi:doi:10.1016/0165-5728(90)90073-V, pages 229 - 237, XP024016435

DOI:   http://dx.doi.org/10.1016/0165-5728(90)90073-V
    - CHENG, G.; X. ZHANG; D. GAO; X. JIANG; W. DONG, "Resveratrol inhibits MMP-9 expression by up-regulating PPAR alpha expression in an oxygen glucose deprivation-exposed neuron model", Neurosci Lett, (20090000), vol. 451, no. 2, doi:doi:10.1016/j.neulet.2008.12.045, pages 105 - 108, XP025922025

DOI:   http://dx.doi.org/10.1016/j.neulet.2008.12.045
    - CRAUSTE, C.; C. VIGOR; P. BRABET; M. PICQ; M. LAGARDE; C. HAMEL; T. DURAND; J. VERCAUTEREN, "Synthesis and Evaluation of Polyunsaturated Fatty Acid-Phenol Conjugates as Anti-Carbonyl-Stress Lipophenols", European Journal Of Organic Chemistry, (20140000), doi:doi:10.1002/ejoc.201402282, pages 4548 - 4561, XP055454417

DOI:   http://dx.doi.org/10.1002/ejoc.201402282
    - DELAUNAY, J. C.; C. CASTAGNINO; C. CHEZE; J. VERCAUTEREN, "Preparative isolation of polyphenolic compounds from Vitis vinifera by centrifugal partition chromatography", J Chromatogr A, (20020000), vol. 964, no. 1-2, doi:doi:10.1016/S0021-9673(02)00355-2, pages 123 - 128, XP004368694

DOI:   http://dx.doi.org/10.1016/S0021-9673(02)00355-2
    - GAO, D.; T. HUANG; X. JIANG; S. HU; L. ZHANG; Z. FEI, "Resveratrol protects primary cortical neuron cultures from transient oxygen-glucose deprivation by inhibiting MMP-9", Mol Med Rep, (20140000), vol. 9, no. 6, pages 2197 - 2204
    - LUPLERTLOP N. et al., "Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction (vol 7, pg 1176, 2006", Embo Rep., (20060000), vol. 7, no. 12, page 1290
    - MARSAC D et al., "Infection of human monocyte-derived dendritic cells by ANDES Hantavirus enhances proinflammatory state, the secretion of acive MMP-9 and indirectly enhances endothelial permeability", Virol J., (20110000), page 8
    - MISSE D. et al., "HIV-1 glycoprotein 120 includes the MMP-9 cytopathogenic factor production that is abolished by inhibition of the p38 mitogen-activated protein kinase signaling pathway", Blood, (20010000), vol. 98, no. 3, pages 541 - 7
    - MOSMANN, T., "Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays", J Immunol Methods, (19830000), vol. 65, no. 1-2, doi:doi:10.1016/0022-1759(83)90303-4, pages 55 - 63, XP023973702

DOI:   http://dx.doi.org/10.1016/0022-1759(83)90303-4
    - WALLE, T., "Bioavailability of resveratrol", Ann N Y Acad Sci, (20110000), vol. 1215, pages 9 - 15
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.